Effects of enzyme induction, renal and cardiac function on ketamine plasma kinetics in patients with ketamine long-term analgosedation
Authors:
- 1 July 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 15 (3) , 259-263
Abstract
Steady-state plasma levels of ketamine and its metabolites norketamine and dehydronorketamine were determined in 4 different groups of a total of 27 patients with ketamine long-term analgosedation (1.1 – 1.3 mg/kg/h). In 9 of the patients who had normal liver and kidney function (group 1), steady-state levels after 3 days of continuous infusion were 1.2±0.3 μg/ml ketamine, 1.0±0.6 μg/ml norketamine, and 2.6±1.0 μg/ml dehydronorketamine. The measured ketamine levels in group 1 were in agreement with the expected value, which may be calculated from published pharmacokinetic data after bolus injection. In 8 patients with acute renal failure (group 2), a tendency to about 20% higher ketamine steady-state plasma levels compared to group 1 was observed, but this difference was not significant. However, dehydronorketamine plasma levels were significantly higher in this group. Only a manor fraction of the ketamine dose (10% and 4%) was eliminated during hemodialysis or hemofiltration treatment, respectively. Steady-state plasma levels in 5 patients with cardiogenic shock (group 3) did not differ significantly from those of group 1. In 5 patients with long-term use of barbiturates (group 4), steady-state plasma levels of ketamine were significantly lower compared to groups 1 and 3, most likely due to barbiturate-induced enzyme induction. Hyperdynamic circulatory reactions were not observed in any of the patients. Psychomimetic effects could be excluded in 16 of the patients and were unlikely in 6 patients. In 5 further patients, psychomimetic effects could not definitely be excluded due to difficulties in non-verbal communication.Keywords
This publication has 16 references indexed in Scilit:
- Kinetics of ketamine and its metabolites in rabbits with normal and impaired renal functionEuropean Journal of Drug Metabolism and Pharmacokinetics, 1985
- The binding of ketamine to plasma proteins: Emphasis on human plasmaEuropean Journal of Clinical Pharmacology, 1983
- Plasma Levels of Ketamine and Two of Its Metabolites in Surgical Patients Using a Gas Chromatographic Mass Fragmentographic AssayAnesthesia & Analgesia, 1982
- PHARMACOKINETICS AND ANALGESIC EFFECT OF KETAMINE IN MANBritish Journal of Anaesthesia, 1981
- Pharmacology of Ketamine Isomers in Surgical PatientsAnesthesiology, 1980
- KETAMINE INFUSIONS: PHARMACOKINETICS AND CLINICAL EFFECTSBritish Journal of Anaesthesia, 1979
- Sympathoneuronal and sympathoadrenal activation during ketamine anesthesiaEuropean Journal of Clinical Pharmacology, 1979
- Rapid gas chromatographie analysis of plasma levels of ketamine and major metabolites employing either nitrogen selective or mass spectroscopic detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1978
- POSTOPERATIVE FLUID AND ELECTROLYTE REQUIREMENTSBritish Journal of Anaesthesia, 1975
- Biotransformation and Disposition of KetamineInternational Anesthesiology Clinics, 1974